Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Tezepelumab
Study Purpose: This study was done to learn how different doses of tezepelumab pass through, break down and leave the body of healthy Chinese participants
Protocol Number: D5180C00020
Thank you!
Thank you for taking part in the clinical study for the study drug tezepelumab.
AstraZeneca AB sponsored this study and believes it is important to share the results. An independent non-profit organization called CISCRP helped prepare this summary of the study results for you.
If you participated in the study and have questions about the results, please speak with the study doctor or staff at your study site.